<DOC>
	<DOCNO>NCT02472431</DOCNO>
	<brief_summary>Autologous adipose-derived regenerative cell ( ADRC ) extract use Celution 800/CRS System ( Cytori Therapeutics Inc ) portion fat harvest patient 's front abdominal wall . ADRC administer one-time intracavernosally . This single arm study control . All patient receive cell therapy .</brief_summary>
	<brief_title>Effectiveness Safety Adipose-Derived Regenerative Cells Treatment Erectile Dysfunction</brief_title>
	<detailed_description>Fat tissue obtainment : Subjects undergo liposuction local anesthesia . In procedure , Ringer 's solution anesthetic lidocaine vasoconstrictor adrenaline infuse adipose compartment minimize blood loss contamination tissue peripheral blood cell . 15 minute later hollow blunt-tipped 3 mm cannula introduce subcutaneous space small ( 0.5 cm ) incision . The cannula attach syringe gentle suction move adipose compartment , mechanically disrupt fat tissue . Aspirate volume - approximately 150-200 cc . Procedure time - 30 minute . ADRC isolation : Aspirated fat tissue place sterile vessel insert Celution 800/CRS System ( Cytori Therapeutics Inc ) - closed system automate standardized extraction concentration ADRC . Celution 800/CRS System drain excess fluid fat tissue estimate 's volume After lipoaspirate wash extensively equal volume Ringer 's solution remove blood . At end process System indicate require volume enzyme reagent ( CelaseÂ® ) add immediately operator . After enzyme treatment Celution 800/CRS System automatically transfer isolate ADRC wash compartment ADRC wash concentrate 5 mL suspension . Tissue processing time - approximately 60 minute . ADRC suspension match requirement list technical documentation Celution 800/CRS System . Obtained ADRC divide 2 portion . First portion ( 0.2-0.5 mL ) use counting , viability sterility assessment . Second portion place sterile insulin syrinx needle size 30 G injection . Intracavernosal injection ADRC : Tourniquet apply immediately prior injection base penis . Penis surround skin treat antiseptic solution . The injection perform lateral surface penis bilaterally proximally middle distal part corpus cavernosum . Needle insert corpus cavernosum depth 5-7 mm . Up 1.0 ml ADRC suspension inject per single injection . Equal portion ADRC suspension inject corpora cavernosa . Tourniquet remove 20 minute ADRC injection .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Impotence , Vasculogenic</mesh_term>
	<criteria>Patient suffers erectile dysfunction IIEF5 score le 21 Endothelial dysfunction confirm EndoPAT measurement Patient familiar Participant information sheet Patient sign informed consent form Noninclusion Criteria : Contraindications local anesthesia medical history allergic reaction local anesthetic Patient prescribed systemic corticosteroid , immunosuppressive drug , nonsteroidal antiinflammatory drug , phosphodiesterase5 inhibitor Medical history penile prosthesis implantation Peyronie 's disease Subcompensated decompensated form chronic disease internal organ Clinically significant abnormality result laboratory test Any condition limit compliance ( dementia , neuropsychiatric disease , drug alcohol abuse etc . ) Participation clinical trial ( administration investigational drug ) 3 month prior inclusion Patients malignant tumor include postoperative period , patient receive chemotherapy and/or radiotherapy . Patient 's activate partial thromboplastin time exceed normal level 1,8 time Patients prescribed anticoagulant treatment patient receive anticoagulant least one hour prior liposuction Medical history heterotopic ossification Patients prescribed glycoprotein inhibitor treatment Patients infection septic condition Patient 's refusal participation trial Chronic kidney disease IV V stage ( creatinine clearance &lt; 30 mL/min estimate CockcroftGault formula ) Confirmed syphilis , HIV , hepatitis B C infection Patients hypogonadism Dropout Criteria : Direct indication immediate initiation treatment drug prove effect erectile function</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>ADRC</keyword>
	<keyword>Adipose-Derived Regenerative Cells</keyword>
	<keyword>Fat Tissue</keyword>
	<keyword>Stem Cells</keyword>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Arteriogenic Impotence</keyword>
	<keyword>Venogenic Impotence</keyword>
	<keyword>Vasculogenic Impotence</keyword>
	<keyword>Male Impotence</keyword>
	<keyword>Male Sexual Impotence</keyword>
</DOC>